Therapeutic strategies such targeting PGRN, which has the potential to both inhibit inflammation and stimulate Treg activity, might present a novel therapeutic concept to treat diverse inflammatory and autoimmune diseases. This evidence concerns the gene GRN and autoimmune disease.